restor3d Launches MyFit Digital Suite for Personalized Orthopedic Care

What MyFit Does

restor3d, a company that builds AI-designed 3D printed implants for shoulders, hips, knees, and ankles, launched MyFit on September 8, 2026. MyFit is a patient engagement platform that connects every step of an implant journey into one view.

Patients use MyFit to track their implant, preview 3D models of their personalized hardware, and follow their case from surgical planning through recovery. Surgeons get the same view, so both sides are working from the same information instead of separate tools.

Building Long-Term Evidence

MyFit includes an optional patient registry designed to follow roughly 2,250 people for five years after surgery. The registry covers knee, hip, shoulder, and foot and ankle procedures. Patients report their outcomes electronically, which reduces paperwork for clinics while building real-world evidence about how well patient-specific implants actually work over time.

Michael Swank, MD of Imperial Health in Lake Charles, Louisiana, said MyFit links three parts of care that usually run in parallel: the patient experience, the technology used, and the outcomes that follow.

Why This Matters

Personalized orthopedics is growing fast, but proving it works at scale is harder than making one custom implant. restor3d already works with more than 520 surgeons across 740 hospitals and has FDA-cleared designs for multiple joint procedures. MyFit pushes the company further upstream into the patient's own experience and downstream into long-term clinical data.

Competitors are trying similar things. Onkos Surgical's My3D platform passed 1,000 pelvic reconstruction cases. Materialise bundles custom implant planning into its Mimics Flow system for cranio-maxillofacial work. The common thread is that everyone wants to own the full patient record, not just the design file.

restor3d has raised $104 million total, with Partners Group coming in during August 2025. The company's steady expansion from implants to software to clinical data suggests the business model is evolving from selling parts to managing outcomes. Whether that changes how hospitals buy orthopedic hardware remains to be seen.